Dailypharm Live Search Close

CKD completes acquiring 3 exclusive licensed items

By Lee, Tak-Sun | translator Alice Kang

22.08.11 12:00:11

°¡³ª´Ù¶ó 0
Completes reimbursement transfer process for Rivotril¡¤Valium¡¤Leustatin that it signed exclusive sales agreements for last year



Chong Kun Dang completed the acquisition process for the three items that it signed exclusive sales agreements for with foreign pharmaceutical companies last year. All three items are known to have a prior history with Chong Kun Dang.

According to industry sources on the 11th, Chong Kun Dang has been receiving insurance reimbursement for the tranquilizer drug ¡®Valium 5mg Tab. (diazepam)¡¯ starting this month. The approval and reimbursement rights for the drug had previously been owned by Roche Korea.

However, after the global commercial rights of the drug were transferred from Roche to Pharmanovia, Chong Kun Dang signed an exclusive sales agreement for Valium in Korea with Pharmanovia i

Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)